Skip to main content

BPC-157 + TB 500

$180.00
(No reviews yet) Write a Review
SKU:
UP-BPC157
Bulk Pricing:
Buy in bulk and save
Adding to cart… The item has been added
Molecular FormulaC62H98N16O22
CAS Number137525-51-0
Molar Mass773.895 g/mol
Amino Acid SequenceGVSWGLR
SynonymsBpc-157, 137525-51-0, Bpc 157, Bepecin Bpc 15, Body protection compound 15
SolubilitySoluble in Water
Organoleptic ProfileWhite powder
CompositionLyophilized powder - requires reconstitution

BPC-157 has been examined for its impact on angiogenesis, collagen synthesis, and modulation of the nitric oxide (NO) system. It has also been shown to affect inflammatory mediators such as cytokines and free radicals.

When analyzed in the laboratory setting, BPC-157 + TB 500 can be used to explore potential synergistic influences on cellular behavior, angiogenesis, and inflammatory pathways.

  • Cellular Behavior in Wound Models: BPC-157 has been studied for its effects on cell migration, angiogenesis, and collagen production in laboratory models of wound healing.
  • Tissue Regeneration Research: BPC-157 may support investigations into tissue repair and regeneration, particularly in tendons, ligaments, and skin.
  • Inflammatory Response Modulation: Studies have explored BPC-157's potential to influence inflammatory cytokines and promote anti-inflammatory effects in experimental systems.
  • Neuroscience Research: BPC-157 has been researched for its possible role in nerve healing and protection of neuronal tissue in preclinical models.
  • Vascular Studies: Research has examined BPC-157's effect on blood vessel formation and vascular integrity, including in models of ischemia and injury.

Based on the available preclinical data, the most common side effects associated with BPC-157 + TB 500 treatment include:

  • Gastrointestinal symptoms: Nausea and mild digestive discomfort have been reported in some preclinical studies, although these effects are generally mild and transient.
  • Injection site reactions: Local reactions at the injection site, such as redness, swelling, and itching, may occur in some research models.
  • Blood pressure fluctuations: Some studies have noted transient changes in blood pressure parameters during administration.

Note: The safety profile of BPC-157 + TB 500 has not been fully established, and further clinical studies are needed to fully evaluate the potential for side effects and long-term safety of BPC-157 + TB 500 in mammals.

This BPC-157 + TB 500 Research Kit is intended solely for laboratory use. It may be employed in structured research settings to study peptide stability, molecular interactions, and delivery mechanisms. The peptide is supplied as a lyophilized, water-soluble powder that must be reconstituted before use. Standard laboratory practices apply, including sterile preparation, controlled storage, and proper disposal in accordance with safety guidelines.

  1. Vukojevic, Katarina et al. "Stable gastric pentadecapeptide BPC 157 and wound healing." Frontiers in pharmacology vol. 12 718147.
  2. Gwyer, Danielle et al. "Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing." Cell and tissue research vol. 383,3 (2021).
  3. Kalogjera, Livije et al. "Stable Gastric Pentadecapeptide BPC 157 in the Therapy of the Nasal Mucosa, Periodontium, and Dry Eye Syndrome." Biomedicines vol. 10,12 3281. 7 Dec. 2022.
  4. Sikiric, Predrag et al. "Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications." Current neuropharmacology vol. 17,11 (2019).
  5. Knezevic, Maro et al. "Stable Gastric Pentadecapeptide BPC 157 Therapy for Periodontitis in Rats." Biomedicines vol. 10,4 859. 6 Apr. 2022.
  6. Kokot, Antonio et al. "Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats." Frontiers in pharmacology vol. 13 861711. 18 Feb. 2022.
  7. Knezevic, Maro et al. "Stable Gastric Pentadecapeptide BPC 157 and Periodontal Healing in Rats." Biomedicines vol. 10,2 265. 25 Jan. 2022.
  8. Sever, Marko et al. "Stable Gastric Pentadecapeptide BPC 157 Therapy for Periodontitis in Rats." Biomedicines vol. 9,7 774. 29 Jun. 2021.
  9. Sikiric, Predrag et al. "Stable Gastric Pentadecapeptide BPC 157-NO-system Relation." Current pharmaceutical design vol. 26,25 (2020).
  10. Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011 Mar;110(3):774-80.
Certificate of Analysis - BPC-157 + TB 500 10mg

Click to enlarge

All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. Neither the products described nor the company are intended to diagnose, treat, cure, or prevent any disease.

Research Peptides Supported by Verifiable Testing

Ultimate Peptides™ is more than just a U.S. supplier of research peptides. We are helping to power the next wave of peptide research, dedicated to providing peptides that support our clients' work.

Consistent Quality Standards

Our internal processes and meticulous sourcing of premium materials help every peptide we offer meet rigorous internal quality standards.

Independently Verified

Every product undergoes extensive testing, both in-house and through independent, third-party laboratories.

Fast Shipping & Support

We provide fast and reliable shipping, using established couriers and high-quality packaging materials to help ensure that your peptides arrive promptly and in optimal condition.